In a moment of exceptional brilliance, Imaad Sohel Ajani, a student of Podar International School, Nerul (CIE Board), has set a new national record by solving the Pyraminx cube in an astonishing 1.01 ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Aligos is "Strong Buy", based ...

The ALGS Open is almost here. These are the elite teams who'll be tearing up the arena in this thrilling tournament. If you’ve not been following the Apex Legends esports scene, now’s a great time to ...

Apex Legends remains one of the most popular first-person shooters year after year, and its esports scene continues to grow ...

ALIGOS THERAPEUTICS ($ALGS) is expected to release its quarterly earnings data on Monday, March 10th before market open, per Finnhub. Analysts are expecting revenue ...

The current meta of the ALGS has been dominated by a mix of shotguns, marksman rifles, and assault rifles. SMGs have seemingly not made the cut, as the latest seasonal patches have reduced their ...

The Apex Legends Global Series has come to Japan for the first time in its history. Sapporo, Hokkaido will welcome Electronic Arts, Respawn Entertainment, and the top Apex Legends players from across ...

We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks.

Aligos Therapeutics focuses on ALG-000184 for CHB and ALG-055009 for MASH, targeting large, underserved markets with growing TAMs. ALG-000184’s Phase 1 data show strong antiviral activity and a ...